Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

The U.S. Food and Drug Administration issued a recall notice Tuesday for several lots of six products, including Walgreens ...

U.S. health officials are asking retailers to pull a small number of acne creams from their store shelves after government ...

Acne creams from retailers including Walgreens, La Roche-Posay and Proactiv have been voluntarily recalled due to elevated levels of a potentially cancer-causing agent.

Parent company La Roche-Posay has pulled the Effaclar Duo Acne Spot Treatment from L'Oreal's lineup, due to a cancer-causing carcinogen contamination.

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...

A voluntary recall issue has been served for a popular La Roche-Posay product in the US after it was found among 66 leading ...

Posay's Effaclar Duo acne treatment over concerns of benzene contamination, a known carcinogen. But skin experts say you ...

In what it says is the biggest obesity deal to date, Zealand Pharma A/S has signed up Roche AG to a potential $5.3 billion ...

Roche and Zealand reason petrelintide could deliver weight loss comparable to glucagon-like peptide 1 (GLP-1) receptor ...

Profits and losses for petrelintide and the petrelintide/CT-388 combination will be shared on a 50:50 basis in the U.S. and Europe, while Zealand will be eligible to receive tiered double-digit ...

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, ...